Eduardo Nava studied at the Autonoma University of Madrid, Spain, where he completed his degree in Medicine as well as a PhD with the doctoral dissertation In vitro study of the internal carotid system. In 1990, he continued the scientific career as a post-doctoral fellow within the framework of the prostaglandin and nitric oxide research leader, Prof. S. Moncada, by then at the Wellcome Research Labs in London, UK. In 1993, he was recruited by Professor Thomas F. Lüscher at the University Hospital Berne where they studied the role of nitric oxide in high blood pressure and developed several techniques for the determination of nitric oxide synthase in the heart and resistance vessels of hypertensive animals. In 1995 he returned to Spain at the University of Murcia with prof. Salazar to keep on the research in the field of the biology of nitric oxide in hypertension, aging and septic shock.
In 1999, Dr. Nava was appointed as a Lecturer in Physiology at the University of Castilla-La Mancha in Spain and in 2019 he was appointed as a professor in this university.
His current research includes the role of perivascular adipose tissue in microvascular function in metabolic syndrome and hypertension as well as the paracrine roles of perivascular adipose tissue in the control of vasomotion.